Navigation Links
Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine
Date:4/15/2008

ory, symptoms, or signs of ischemic cardiac, cerebrovascular, or peripheral vascular syndromes and in patients with other significant underlying cardiovascular diseases. Treximet should not be given to patients in whom unrecognized coronary artery disease is predicted by the presence of risk factors without a prior cardiovascular evaluation. Treximet should not be given to patients with uncontrolled hypertension because the components have been shown to increase blood pressure. Concurrent administration of MAO-A inhibitors or use of Treximet within two weeks of discontinuation of MAO-A inhibitor therapy is contraindicated. Treximet and any ergotamine-containing or ergot-type medication (like dihydroergotamine and mthysergide) should not be used within 24 hours of each other. Since Treximet contains sumatriptan, it should not be administered with another 5-HT1 agonist. Treximet is contraindicated in patients with hepatic impairment. Treximet is contraindicated in patients who have had allergic reactions to products containing naproxen. It is also contraindicated in patients in whom aspirin or other NSAIDs/analgesic drugs induce the syndrome of asthma, rhinitis, and nasal polyps. Both types of reactions have the potential of being fatal. Treximet is contraindicated in patients with hypersensitivity to sumatriptan, naproxen, or any other component of the product. Cerebrovascular events have been reported in patients treated with sumatriptan. In a number of cases, it appears possible that the cerebrovascular events were primary. It is important to advise patients not to administer Treximet if a headache being experienced is atypical. The development of a potentially life-threatening serotonin syndrome may occur with triptans, including treatment with Treximet, particularly during combined use with selective serotonin reuptake inhibitors (SSRIs) or selective norepinephrine reuptake inhibitors (SNRIs). NSAID-containing products, including Treximet, should be prescribed wi
'/>"/>
SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained With Naproxen Sodium
2. FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium) sNDA for Short-Term Treatment of GERD in Adolescents
3. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
4. Keppra XR(TM) Extended-Release Tablets Filed with the FDA
5. UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
6. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
7. New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
10. Newly Approved HIV Drug Shows Great Promise
11. Nexavar First FDA-Approved Drug Therapy for Liver Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... , Nov. 24, 2014  Marta Rendon, MD, founder of ... Boca Raton , FL and international key opinion leader in ... the United States to attend the ... Istanbul, Turkey . Here, at this gathering of over ... world renowned facial plastic surgery experts from Asia ...
(Date:11/24/2014)... -- GlySens Incorporated announced today that it has been awarded ... Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), ... The grant is intended to support human clinical evaluation ... glucose monitoring system.  Final preparations for launch of the ... before the end of 2014. "We are ...
(Date:11/23/2014)... -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), ... and Chief Executive Officer, will present a corporate update ... Anthera will present at 4:30PM ET, December ... New York City . ... biopharmaceutical company focused on developing and commercializing products to ...
Breaking Medicine Technology:Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health 2Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference 2
... /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP ... the Company plans to release third quarter 2010 financial ... closes. The Company will hold a conference ... to discuss its results.  Listeners may access the call ...
... Pharmaceuticals, Inc. (Nasdaq: REGN ) will webcast ... Conference on Wednesday, November 10, 2010.  The presentation is ... Time).  The session may be accessed through the Company,s ... page.  An archived version of the presentation will be ...
Cached Medicine Technology:BMP Sunstone to Report Third Quarter 2010 Financial Results 2
(Date:11/23/2014)... TX (PRWEB) November 23, 2014 ... market such as its significance, programs and manufacturing ... and Chinese suppliers major market gamers in information. ... information, item specifications, prospective, manufacturing value, and 2009-2014 ... research, the evaluation symbolizes the globally and Chinese ...
(Date:11/23/2014)... SWAccessControl.com's high quality access control power suppliers are ... announced its new collection of power suppliers. Additionally, it ... power suppliers. All the new models come with big ... until Dec. 20, 2014. , SWAccessControl.com has thousands of ... it for a long time. It is very wise ...
(Date:11/23/2014)... AngelWeddingDress.com has recently updated its online ... wedding dresses. “If you are looking for gorgeous beach ... as possible. Here you can enjoy 70% off discounts ... Holding a big marriage ceremony is the most important ... wedding dress is uppermost priority. Ophelia, one of customers, ...
(Date:11/23/2014)... 2014 “BlackVue” was featured on NewsWatch ... which features the latest and coolest technology products available ... for NewsWatch, conducted the product review and shared with ... options in the car camera industry. , The need ... be hard to find the one that’s right per ...
(Date:11/23/2014)... Syngenta lawsuits are now being investigated by ... agribusinesses that have allegedly incurred significant financial damages due ... Agrisure Duracade, genetically modified (GMO) corn seed products ... China. According to a report from Bloomberg News, Syngenta’s ... imports. Because China is the third-largest American corn importer, ...
Breaking Medicine News(10 mins):Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2Health News:Beach Wedding Dresses Added to Outstanding Online Dress Company AngelWeddingDress.com 2Health News:A Leader in Front and Rear Facing In-Car Cameras was Featured on NewsWatch Television on October 30, 2014 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3
... an important signaling pathway that, when blocked, significantly decreases ... their study, researchers at The University of Texas MD ... the Notch pathway in mice decreased metastases in the ... studies were reported Sunday in an oral presentation at ...
... MADISON Researchers may have pinpointed a reason many ... in the journal Addiction, smokers with a history of ... study, conducted by the University of Wisconsin Center for ... medications to smokers in Madison and Milwaukee. , While ...
... The arteries of obese children have a degree of stiffness ... new study. Canadian researchers evaluated 63 obese children, average ... had abnormal results on an ultrasound test of the heart ... the body. Of special note was stiffness of ...
... new tools that enable the public to report sick or ... containment of wildlife disease outbreaks that may pose a health ... is a new website at www.wher.org that enables ... or dead wildlife. ,HealthMap.org has enhanced its mobile phone ...
... Behen HealthDay Reporter , SUNDAY, Oct. 24 (HealthDay ... topic of late: Just last week, the National Football League ... hits that often result in head injuries. Now, a ... years, players have been sidelined significantly longer after concussions than ...
... of a number of new Canadian Cardiovascular Society ... to date information to support clinicians in practicing ... Congress 2010 this week. Among them are the ... antiplatelet therapy guidelines , CCS position statement on ...
Cached Medicine News:Health News:Researchers find pathway that drives spread of pediatric bone cancer in preclinical studies 2Health News:Common anxiety disorders make it tougher to quit cigarettes 2Health News:Arteries of Obese Kids Aging Prematurely: Study 2Health News:Wildlife health reporting tools may help prevent human illness 2Health News:Wildlife health reporting tools may help prevent human illness 3Health News:NFL Players With Concussions Sidelined Longer: Study 2Health News:NFL Players With Concussions Sidelined Longer: Study 3Health News:Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010 2Health News:Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010 3Health News:Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010 4Health News:Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010 5Health News:Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010 6Health News:Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010 7Health News:Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010 8Health News:Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010 9
The Bledsoe Achilles Boot saves time by eliminating casting series required to stretch the achilles tendon during rehab....
Get back into action with MalleoLoc. Perfect for playing basketball, volleyball or everyday activities. The MalleoLoc stabilizing ankle brace increases ankle stability without restricting mobility....
DarcoGel™ Upper chamber is foam filled, conforms to calf; gel-filled lower chamber molds to the malleoli for a custom fit. Freeze the removable liner for cold therapy. One size. Fits left or ri...
Softsplint after bunion surgery. Hook-and-loop closure. Maintains hallux positioning and metatarsophalangeal alignment. Washable....
Medicine Products: